DALRD3抗体—艾普蒂

+ +

•  

   

     Gel: 8%SDS-PAGE, Lysate: 40 μg, Lane: HepG2 cell lysate, Primary antibody: P09586(DALRD3 Antibody) at dilution 1/550, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 20 seconds    

  
  

•  

   

     The image is immunohistochemistry of paraffin-embedded Human liver cancer tissue using P09586(DALRD3 Antibody) at dilution 1/25. (Original magnification: ×200)    

  
  

The DALRD3 (DALR anticodon binding domain containing 3) protein is encoded by the DALRD3 gene and is characterized by the presence of a conserved DALR domain, which is implicated in tRNA recognition and translation regulation. This domain, shared with other tRNA-modifying enzymes, suggests DALRD3's potential role in RNA binding or post-transcriptional modification processes. While its precise biological function remains under investigation, DALRD3 is hypothesized to influence cellular pathways related to protein synthesis, cell cycle progression, or stress responses. Studies have linked it to interactions with components of the translational machinery, though its mechanistic contributions are not fully elucidated.

DALRD3 antibodies are immunological tools developed to detect and study the expression, localization, and molecular interactions of the DALRD3 protein. These antibodies are commonly used in techniques such as Western blotting, immunofluorescence, and immunoprecipitation to explore DALRD3's tissue distribution, subcellular localization (e.g., cytoplasmic or nuclear), and expression changes under physiological or pathological conditions. Some research suggests DALRD3 may be dysregulated in cancers or neurological disorders, making its antibodies valuable for biomarker discovery or functional studies. Commercial DALRD3 antibodies are typically raised in hosts like rabbits or mice, with validation data confirming specificity against conserved epitopes. Ongoing research aims to clarify DALRD3's role in disease and its potential as a therapeutic target.